Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
09/20/1989 | EP0332826A1 Injectable pharmaceutical compositions having improved stability, and methods of producing the same |
09/20/1989 | EP0197987B1 Process for preparing a solution of inverted micellae |
09/20/1989 | CN1035619A Human relaxin formulation |
09/19/1989 | US4868220 Lanolin substitute and composition containing the same |
09/19/1989 | US4868218 Method of treating depression |
09/19/1989 | US4868214 Ketoprofen enantiomer |
09/19/1989 | US4868180 Vitamin-containing granules and production thereof |
09/19/1989 | US4868170 Steriod lotion formulation |
09/19/1989 | US4868169 Steroid cream formulation |
09/19/1989 | US4868168 Tipredane, stability, antiinflammatory agent |
09/19/1989 | US4868158 Method for the production of a macromolecular carrier loaded with a biologically active substance |
09/19/1989 | US4867989 Metal salts for improved nutrition |
09/19/1989 | US4867988 Dentifrice containing microencapsulated oxygen |
09/19/1989 | US4867987 Pharmaceutical product for the sustained release of ibuprofen |
09/19/1989 | US4867986 Dry stabilized microemulsified omega-three acid-containing oils |
09/19/1989 | US4867985 Spheroids |
09/19/1989 | US4867984 Aspirin, acetomenophen |
09/19/1989 | US4867983 Method for double dipping gelating coated caplets |
09/19/1989 | US4867982 Transdermal drug delivery device |
09/19/1989 | US4867980 Heavy density depot |
09/19/1989 | US4867976 Dipheria toxin |
09/19/1989 | US4867970 Ointment containing hydrocolloid, nonhardening |
09/19/1989 | US4867969 Hydrogel formulation for administering non-steroidal drugs |
09/19/1989 | US4867964 Sunscreen |
09/19/1989 | US4867942 Reacting with water or alcohol, coating with carbonate |
09/19/1989 | EP0313617A4 Lipid emulsion and method for intravenous infusion. |
09/19/1989 | CA1259750A1 Muramylpeptide lipophilic derivatives activating macrophages, compositions comprising same and process for obtaining them |
09/19/1989 | CA1259567A1 Method for the microencapsulation by phase separation of medicamentous water-soluble substances |
09/14/1989 | DE3905394A1 Process for the production of biocompatible, water-soluble, inorganic glasses and their use |
09/13/1989 | EP0332600A1 Pharmaceutical compositions containing cholestyramine |
09/13/1989 | EP0332530A1 Polymers from citric acid and diamines, process for their preparation and their user as vectors for medicines |
09/13/1989 | EP0332478A1 Liposomes containing Scutellaria extracts |
09/13/1989 | EP0332222A2 Intravaginal delivery of biologically active polypeptides |
09/13/1989 | EP0332175A2 Method of producing microcapsule |
09/13/1989 | EP0332147A2 Compositions with enhanced penetration |
09/13/1989 | EP0332094A1 Oral delivery systems with controlled drug release |
09/13/1989 | EP0332022A2 Magnetic protein conjugates, process for their production and their use |
09/13/1989 | EP0332010A2 Method for making a dressing for transdermal delivery of pharmaceuticals |
09/13/1989 | EP0331833A1 Water-in-oil emulsion type cosmetics |
09/13/1989 | EP0331755A1 Medicine-containing fat emulsion of the type prepared immediately before use and process for preparing medicine-containing fat emulsion |
09/13/1989 | CN1035507A Freeze-dried pharmaceutical preparations for parenteral use |
09/13/1989 | CN1035435A Metrohidazole formulations and therapeutical uses thereof |
09/13/1989 | CN1035433A Pharmaceutical granulate |
09/12/1989 | US4866097 Controlled release system |
09/12/1989 | US4866096 Stable fluorochemical aqueous emulsions |
09/12/1989 | US4866088 Preparation process for an aqueous pharmaceutical solution of an active principle constituted by an organic acid |
09/12/1989 | US4866051 Micronised beclomethasone dipropionate monohydrate compositions and methods of use |
09/12/1989 | US4866049 Ophthalmic compositionn and method of using same |
09/12/1989 | US4866046 Low-dosage sublingual aspirin |
09/12/1989 | US4866044 Solubilized composition of poorly-soluble pharmaceutical product |
09/12/1989 | US4866040 Aminocarnitine directed pharmaceutical agents |
09/12/1989 | US4865851 Pharmaceutical composition comprising cefuroxime axetil |
09/12/1989 | US4865850 Dietary fat reduction |
09/12/1989 | US4865849 Multilayer, disintegration, cellulose derivative or polyvinyl alcohol, polymer casing |
09/12/1989 | US4865848 Skin permeation enhancer compositions using sucrose esters |
09/12/1989 | US4865846 Drug delivery system |
09/12/1989 | US4865845 Sleeves, weakening |
09/12/1989 | US4865844 Antimicrobial organosilane quaternary ammonium salt |
09/12/1989 | US4865843 Dried and ground corn silks and parsley roots |
09/12/1989 | US4865838 Composition for setting the hairdo and grooming the hair |
09/12/1989 | US4865836 Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport |
09/12/1989 | US4865835 Diagnosis and treatment of tumors |
09/12/1989 | US4865789 Method for making porous structures |
09/12/1989 | US4865598 Dispensing system for administering beneficial agent |
09/12/1989 | CA1259181A1 Tobacco compositions, method and device for releasing essentially pure nicotine |
09/08/1989 | WO1989008148A2 Process for preparing aqueous suspensions or slurries from cellulose microfibrils, cellulose microfibril aqueous suspension or slurry and its use |
09/08/1989 | WO1989008130A1 Immobilized artificial membranes |
09/08/1989 | WO1989008127A1 Solubilization of complexes of water-insoluble organic compounds by aqueous solutions of polyvinylpyrrolidone |
09/08/1989 | WO1989007959A1 Occlusive body for administering a physiologically active substance |
09/08/1989 | WO1989007951A1 Transdermal estradiol delivery system |
09/08/1989 | WO1989007950A1 Transdermal multipolymer drug delivery system |
09/08/1989 | WO1989007945A1 Human relaxin formulation |
09/08/1989 | WO1989007941A1 Water-soluble complexes of pharmaceuticals |
09/08/1989 | WO1989007937A1 Mucin directed liposome |
09/08/1989 | WO1989007936A1 Integrity protected gelatin |
09/08/1989 | WO1989007935A1 Polymer composite for controlled release or membrane formation |
09/08/1989 | WO1989007934A1 Twin-chamber syringe filled with a charge of activity-sensitive human protein as active substance |
09/08/1989 | WO1989007929A1 Method and apparatus for producing lipid vesicles |
09/08/1989 | WO1989007922A1 Primary packaging for surface-stabilized surgical dressings |
09/06/1989 | EP0331635A2 Preparations for treating bladder cancer |
09/06/1989 | EP0331505A1 A method for purification of liposome composition |
09/06/1989 | EP0331504A1 Liposome composition |
09/06/1989 | EP0331392A2 Anesthesia and antisepsis of the skin |
09/06/1989 | EP0331391A1 Method for reducing sensitization or irritation in transdermal drug delivery and means therefor |
09/06/1989 | EP0331385A2 Aqueous suspension of sucralfate |
09/06/1989 | EP0331382A2 Transdermal flux enhancing compositions |
09/06/1989 | EP0331152A1 Two-component syringe with a filling of sensitive human protein as the active ingredient |
09/06/1989 | EP0331092A2 Alpha-amino-carboxylic-acid derivatives, their preparation and use |
09/06/1989 | EP0330825A1 Initial packaging for a surface-stabilized bandages |
09/06/1989 | EP0330801A1 Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease |
09/06/1989 | EP0330786A1 Topical drug delivery systems containing danazol |
09/06/1989 | EP0330665A1 Hydrosoluble ubidecarenones derivatives and their preparation |
09/06/1989 | CN1035243A Method for preparing externally used contraceptive tablet of plant hemagglutinin |
09/06/1989 | CN1035242A Pharmaceutical composition for 4-aroylimidazol-2-ones |
09/05/1989 | USH672 Stable antifungal capsule formulation |
09/05/1989 | US4863970 Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols |
09/05/1989 | US4863952 Method of promoting percutaneous drug absorption with 2-pyrrolidin-2-one 5-carboxylic acids and esters thereof |
09/05/1989 | US4863950 Gelatin, l-cystine, synergistic |
09/05/1989 | US4863907 Crosslinked glycosaminoglycans and their use |
09/05/1989 | US4863896 Diabetic control by combined insulin forms |